273 related articles for article (PubMed ID: 2085427)
21. [Dialysate and biocompatibility in hemodialysis].
Berland Y
Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
[TBL] [Abstract][Full Text] [Related]
23. High-flux dialyzers, backfiltration, and dialysis fluid quality.
Schiffl H
Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
[TBL] [Abstract][Full Text] [Related]
24. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
Lonnemann G; Koch KM; Shaldon S; Dinarello CA
J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
[TBL] [Abstract][Full Text] [Related]
25. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
26. Role of bradykinin in anaphylactoid reactions during hemodialysis with AN69 dialyzers.
Schaefer RM; Fink E; Schaefer L; Barkhausen R; Kulzer P; Heidland A
Am J Nephrol; 1993; 13(6):473-7. PubMed ID: 8141183
[TBL] [Abstract][Full Text] [Related]
27. No evidence for endotoxin transfer across high flux polysulfone membranes.
Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B
Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251
[TBL] [Abstract][Full Text] [Related]
28. Measurement of backfiltration rates during hemodialysis with highly permeable membranes.
Leypoldt JK; Schmidt B; Gurland HJ
Blood Purif; 1991; 9(2):74-84. PubMed ID: 1760145
[TBL] [Abstract][Full Text] [Related]
29. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
[TBL] [Abstract][Full Text] [Related]
30. When good water goes bad: how it happens, clinical consequences and possible solutions.
Lonnemann G
Blood Purif; 2004; 22(1):124-9. PubMed ID: 14732820
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
[TBL] [Abstract][Full Text] [Related]
32. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis.
Canivet E; Lavaud S; Wong T; Guenounou M; Willemin JC; Potron G; Chanard J
Am J Kidney Dis; 1994 Jan; 23(1):41-6. PubMed ID: 8285196
[TBL] [Abstract][Full Text] [Related]
33. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.
Schiffl H; Fischer R; Lang SM; Mangel E
Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the microbiological quality of dialysate and treated water.
Asserraji M; Maoujoud A; Belarbi M; Elfarouki R
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):91-5. PubMed ID: 24434388
[TBL] [Abstract][Full Text] [Related]
35. [High-efficiency membranes and the dialysis solution].
Agliata S; Airoldi G; Baroni A; Boschetti M; Schweiger K; Fortina F; Ragazzoni E; Cavagnino A
Minerva Urol Nefrol; 1990; 42(1):39-42. PubMed ID: 2389221
[TBL] [Abstract][Full Text] [Related]
36. Detection of endotoxin antibody in long-term dialysis patients.
Yamagami S; Adachi T; Sugimura T; Wada S; Kishimoto T; Maekawa M; Yoshimura R; Niwa M; Terano Y; Shaldon S
Int J Artif Organs; 1990 Apr; 13(4):205-10. PubMed ID: 2115504
[TBL] [Abstract][Full Text] [Related]
37. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
Vanholder RC; Ringoir SM
Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
[TBL] [Abstract][Full Text] [Related]
38. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
Ifediora OC; Teehan BP; Sigler MH
ASAIO J; 1992; 38(3):M697-701. PubMed ID: 1457952
[TBL] [Abstract][Full Text] [Related]
39. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
[TBL] [Abstract][Full Text] [Related]
40. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
